Volume 5, Number 1—February 1999
Perspective
The Economic Impact of Staphylococcus aureus Infection in New York City Hospitals
Table 3
Incidence of Staphylococcus aureus infections from research or clinical panel
| Type of infection | Description | S. aureus % | Reference |
|---|---|---|---|
| Bacteremia | Staphylococcal septicemia | 50 | 30 |
| Bacteremia | 15 | 31,32 | |
| Infection and inflammatory reaction due to internal vascular device, implant, and graft | 16 | 4 | |
| Endocarditis | Acute and subacute bacterial endocarditis | 30 | Clinical panel |
| Infection and inflammatory reaction due to cardiac device, implant, and graft | 14 | 33 | |
| Surgical site infection | Disruption of operation wound and postoperative infection | 20 | 4 |
| Osteomyelitis | Acute and chronic osteomyelitis | 50 | 34,35 |
| Septic arthritis | Pyogenic arthritis | 11 (age <5 yr) | 33 |
| 33 (age 5-18 yr) | |||
| 55 (age >18 yr) | |||
| Infection and inflammatory reaction due to internal joint prosthesis | 25 | 33 |
Page created: December 07, 2010
Page updated: December 07, 2010
Page reviewed: December 07, 2010
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.